NCT00096863View on ClinicalTrials.gov

The MIND Study: Modifying the INcidence of Delirium

PHASE2CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
DeliriumCognition Disorders
Interventions
DRUG

Ziprasidone

DRUG

Haloperidol

OTHER

Placebo

Trial Locations (5)

27401

Moses Cone, Greensboro

27599

University of North Carolina - Chapel Hill, Chapel Hill

37205

Saint Thomas Hospital, Nashville

37232

Vanderbilt University Medical Center, Nashville

52242

University of Iowa, Iowa City

All Listed Sponsors
lead

Vanderbilt University

OTHER

NCT00096863 - The MIND Study: Modifying the INcidence of Delirium | Biotech Hunter | Biotech Hunter